Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond annotations (readOnly, idempotent, openWorld), the description reveals that for 'company' it pulls specific financial metrics (revenue, net income, cash, debt) with correct fiscal year handling, and for 'drug' it pulls adverse-event counts, approval counts, and trial counts. It also states results are sorted by primary metric and includes citation URIs, adding significant behavioral context.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness5/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is concise and front-loaded with trigger phrases and imperative guidance. Every sentence provides necessary information without redundancy, making it efficient for an AI agent to parse and understand.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given no output schema, the description adequately explains return values (paired data + pipeworx:// citation URIs) and covers both entity types comprehensively. It also estimates the efficiency gain (replaces 8-15 lookups), providing sufficient context for tool selection.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so baseline is 3. The description adds meaning by clarifying 'values' uses tickers/CIKs for companies and drug names for drugs, and explicitly states the min/max limits (2-5) already in schema, but also explains the purpose of the 'type' enum, enhancing clarity beyond the schema.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

Description uses specific verbs ('compare', 'side-by-side comparison') and clearly states the resource (2-5 companies or drugs) and action. It further specifies data sources (SEC EDGAR/XBRL for companies, FAERS for drugs) and distinguishes from sequential lookups, making the purpose unambiguous.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Description explicitly states 'ALWAYS PREFER over sequential single-pack lookups' and provides natural language triggers (e.g., 'compare X and Y', 'which is bigger'). It lacks explicit when-not-to-use scenarios, but the context is clear enough for most use cases.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Several tools occupy overlapping roles: ask_pipeworx, ask_pipeworx_beta, and ask_pipeworx_grounded are near-identical entry points (beta currently behaves exactly like stable), while entity_profile, recent_changes, and compare_entities all target company research. The prediction-market cluster (bet_research, polymarket_edges, polymarket_arbitrage, polymarket_edge_tracker, polymarket_fill_risk, polymarket_kalshi_spread) is large enough that an agent could easily select the wrong one.

Naming Consistency2/5

Naming conventions are mixed throughout: verb_noun patterns (search_dois, list_repositories, validate_claim) coexist with noun phrases (entity_profile, recent_alerts, ai_visibility_check) and bare verbs (remember, recall, forget, subscribe). The only consistent thread is snake_case, but the grammatical style is unpredictable.

Tool Count2/5

At 34 tools, the server is overstuffed, especially given its apparent focus is DataCite but only 3 tools actually serve that domain (get_doi, search_dois, list_repositories). The rest are a grab bag of Pipeworx data routing, prediction-market analytics, memory, and subscription utilities that would be better split into separate focused servers.

Completeness2/5

The DataCite surface is incomplete (no DOI creation, update, or deletion despite DataCite supporting registration), while the Pipeworx surface has no direct fetch-by-URI tool for the pipeworx:// citations that other tools return. The presence of a duplicate beta router and a beta router with no active differences further muddies the coverage picture.